Artidis

Decoding the physics of cancer

Artidis AG is a clinical-stage health-technology and medtech company based in Basel, Switzerland. It originated as a spin-off from research at the Biozentrum and the Swiss Nanoscience Institute at the University of Basel. The company has developed a proprietary nanotechnology platform that measures the nanomechanical properties of tissue biopsies—capturing physical signatures that help differentiate between benign and malignant tissue and assess tumor behavior. This technology, integrated with advanced data analytics via the ARTIDISNet digital platform, enables much faster cancer diagnosis and supports personalized treatment optimization by physicians, potentially reducing diagnostic times from days to just a few hours. Artidis’ innovation is focused on transforming cancer diagnostics and treatment planning through its unique biomarker and digital platform approach.